Product Information
SUMATRIPTAN SUCC 25 MG TABLET is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.2509 per EA under NDC 62756052088. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Aug 10, 2009.
Strength
25 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756052088
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA078295FDA Approved
8/10/2009
On Market Since
8/10/2009
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN SUCC 25 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 71.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2509 per EA |
|---|---|
| All-time high | $1.1120 (Feb 12, 2014) |
| All-time low | $0.2509 (Aug 19, 2026) |
| 52-week high | $0.3363 |
| 52-week low | $0.2509 |
| Median price | $0.7118 |
| Average price | $0.6531 |
| Largest weekly change | +48.8% (May 22, 2019) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
-11.7%
6M
-2.9%
1Y
-25.0%
3Y
-30.4%
5Y
-66.4%
All
-71.8%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
sumatriptan succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN SUCC 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN SUCC 25 MG TABLET, manufactured by Sun Pharmaceutical Industries Inc., is $0.2509 per EA (NDC 62756052088), effective Aug 19, 2026.
How has the price of SUMATRIPTAN SUCC 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN SUCC 25 MG TABLET has declined 71.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN SUCC 25 MG TABLET?
Since Nov 28, 2013, the NADAC for SUMATRIPTAN SUCC 25 MG TABLET has ranged from a low of $0.2509 (Aug 19, 2026) to a high of $1.1120 (Feb 12, 2014), with a median of $0.7118 per EA.
Are there cheaper alternatives to SUMATRIPTAN SUCC 25 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN SUCC 25 MG TABLET, is $0.2394 per EA — about 5% below SUMATRIPTAN SUCC 25 MG TABLET.
Who manufactures SUMATRIPTAN SUCC 25 MG TABLET?
SUMATRIPTAN SUCC 25 MG TABLET (NDC 62756052088) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.